Health Sciences Gr Stock Cash Flow From Operations
Health Sciences Gr fundamentals help investors to digest information that contributes to Health Sciences' financial success or failures. It also enables traders to predict the movement of Health Pink Sheet. The fundamental analysis module provides a way to measure Health Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Health Sciences pink sheet.
Health |
Health Sciences Gr Company Cash Flow From Operations Analysis
Health Sciences' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Health Sciences Cash Flow From Operations | 38.99 K |
Most of Health Sciences' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Sciences Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Competition |
In accordance with the recently published financial statements, Health Sciences Gr has 38.99 K in Cash Flow From Operations. This is 99.99% lower than that of the Food & Staples Retailing sector and 99.94% lower than that of the Consumer Staples industry. The cash flow from operations for all United States stocks is 100.0% higher than that of the company.
Health Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health Sciences' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Health Sciences could also be used in its relative valuation, which is a method of valuing Health Sciences by comparing valuation metrics of similar companies.Health Sciences is currently under evaluation in cash flow from operations category among related companies.
Health Fundamentals
Return On Asset | -0.73 | |||
Operating Margin | (73.91) % | |||
Current Valuation | 39.41 K | |||
Price To Sales | 0 X | |||
Revenue | 358.43 K | |||
Gross Profit | 22.91 K | |||
EBITDA | (4.51 M) | |||
Net Income | (54.49 K) | |||
Cash And Equivalents | 1.71 K | |||
Total Debt | 407 K | |||
Current Ratio | 0.01 X | |||
Book Value Per Share | (0.11) X | |||
Cash Flow From Operations | 38.99 K | |||
Earnings Per Share | (0.13) X | |||
Beta | -28.36 | |||
Market Capitalization | 281 | |||
Total Asset | 1.03 M | |||
Retained Earnings | (32.46 M) | |||
Working Capital | (5.04 M) | |||
Current Asset | 67 K | |||
Current Liabilities | 5.11 M | |||
Z Score | -61.4 | |||
Annual Yield | 0.05 % | |||
Net Asset | 1.03 M |
About Health Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health Sciences Gr's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Sciences Gr based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Health Sciences Gr. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Health Pink Sheet analysis
When running Health Sciences' price analysis, check to measure Health Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Sciences is operating at the current time. Most of Health Sciences' value examination focuses on studying past and present price action to predict the probability of Health Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Sciences' price. Additionally, you may evaluate how the addition of Health Sciences to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |